(MedPage Today) — France recently became the first country to approve intravenous racemic ketamine for adults in severe suicidal crisis, which “could help close the key gap between recognizing an acute suicidal crisis and delivering an intervention…
Source:
www.medpagetoday.com
Medical Disclaimer:
This content is shared for informational and educational purposes only.
It does not constitute medical, legal, or policy advice.
Healthcare decisions should always be made in consultation with qualified professionals.
